SYLMAR, Calif.–(BUSINESS WIRE)–Second Sight Medical Products, Inc. (NASDAQ:EYES) (“Second Sight” or “the Company”), a developer, manufacturer and marketer of implantable visual prosthetics to restore functional vision to blind patients, today announced two senior management appointments in commercialization and manufacturing. As discussed on its fourth quarter 2014 conference call, the Company will be making several key hires as it continues the transition from an R&D focused organization
IRVINE, Calif. & BEDMINSTER, N.J. & RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) (the “Company”), announced today that its first quarter 2015 financial results will be released after the market closes on Thursday, May 7, 2015. Following the release, the Company will host a live conference call and webcast at 5:00 p.m. Eastern Time to discuss the Company’s financial results and provide a general business and strategic update. Additionally, the Company
BOSTON–(BUSINESS WIRE)–Stealth BioTherapeutics (Stealth), a clinical-stage biopharmaceutical company developing drug candidates for mitochondrial dysfunction, today announced expansion of its ophthalmology program.
COLUMBUS, Ohio–(BUSINESS WIRE)–The Cataract & Refractive Center of Ohio released an advisory alert to educate people across the Midwest about a new treatment for chronic eye problems suffered by millions of Americans. Those problems are often worse during the spring in the Midwest, when the air is flooded with pollen from maple trees and other plants. In the advisory, Alice T. Epitropoulos, MD, FACS, co-founder of The Eye Center of Columbus, explains that more than 23 million Americans su
TOKYO–(BUSINESS WIRE)–R-Tech Ueno (JASDAQ:4573) This is to announce that R-Tech Ueno, Ltd. (Head Office: Chiyoda-ku, Tokyo, CEO and President: Yukihiko Mashima, hereinafter referred to as “R-Tech Ueno”) has acquired the right to develop and commercia…
MURRIETA, Calif.–(BUSINESS WIRE)–II-VI Optical Systems (II-VI OS) will present at the SPIE-DSS show in Baltimore Maryland, April 20-23, 2015, Booth #725.
LONDON–(BUSINESS WIRE)–Technavio has published a new report on the smart glasses market for augmented reality (AR), which is expected to grow at a CAGR 194.2% from 2015-2019.
SUNNYVALE, Calif.–(BUSINESS WIRE)–Phase 3 trial data showed that IBI-10090 is highly effective in treating inflammation post cataract surgery.
PLEASANTON, Calif.–(BUSINESS WIRE)–Clarity Medical Systems, Inc., a developer and marketer of ophthalmic diagnostic imaging technologies, is pleased to announce that their product, RetCam, will be utilized to image premature infant eyes in a study to evaluate a potential new method for treating Retinopathy of Prematurity (ROP) using Lucentis™ (ranibizumab). “The use of RetCam in a study of this medical significance demonstrates the growing worldwide acceptance of RetCam for pediatric retinal
WATERTOWN, Mass.–(BUSINESS WIRE)–pSivida VP of Research to discuss company’s protein and antibody sustained delivery system at upcoming Ocular diseases and drug conference
LAKE FOREST, Calif.–(BUSINESS WIRE)–ReVision Optics®, Inc. (RVO), a leader in implantable inlay technology to treat presbyopia, reported a high level of satisfaction from a group of 58 patients treated for presbyopia at the Ultralase Clinics in the …
SAN DIEGO–(BUSINESS WIRE)–Free app is now available, making Android smartphones more accessible for postpaid and no-contract Sprint customers
SANTA CLARA, Calif.–(BUSINESS WIRE)–OptiMedica begins shipping the Catalys Precision Laser System for cataract surgery in the U.S. First U.S. patients have been treated at Mann Eye Institute in Houston.
ROCKVILLE, Md.–(BUSINESS WIRE)–RegeneRx Biopharmaceuticals, Inc. (OTC Bulletin Board: RGRX) (“the Company” or “RegeneRx”) is updating stockholders on the status of strategic discussions related to its ophthalmic drug candidate, RGN-259. Since…
WATERTOWN, Mass.–(BUSINESS WIRE)–pSivida to hold conference call Monday to discuss product pipeline and CRL from FDA for ILUVIEN
MIAMI–(BUSINESS WIRE)–OPKO Health, Inc. (NYSE: OPK) has agreed to sell its ophthalmic instrumentation business to OPTOS, Inc., a subsidiary of Optos plc, a leading and rapidly growing medical technology company engaged in the design, development, man…
GAINESVILLE, Fla.–(BUSINESS WIRE)–AGTC receives significant grant funding from the Foundation Fighting Blindness to develop treatment for genetic eye disease, XLRS, causing blindness in young boys.
SEATTLE & TOKYO–(BUSINESS WIRE)–Acucela Inc., a clinical-stage biotechnology company focused on developing new treatments for blinding eye diseases, and Otsuka Pharmaceutical Co., Ltd., today announced the initiation of a Phase 1/2 clinical trial for…
SARcode Bioscience, Inc., a privately-held biopharmaceutical company, announced today the completion of a $44 million Series B private equity financing. The financing round was led by Sofinnova Ventures and was augmented by the additional backing of Rh…
PowerVision, Inc., a private company developing an accommodating intraocular lens, announced that it had added Medtronic to its list of investors in a recent closing of its Series C financing. Stephen Oesterle, MD, Senior Vice President, Medicine and T…